Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 136,734 | 58,896 | 148,643 | 99,574 | 64,552 |
| Marketable Securities | 584,801 | 640,706 | 489,439 | 427,100 | 475,048 |
| Receivables | 853 | 833 | 874 | 805 | 2,123 |
| TOTAL | $728,089 | $707,204 | $644,962 | $531,008 | $544,616 |
| Non-Current Assets | |||||
| PPE Net | 10,138 | 9,393 | 9,653 | 10,236 | 9,563 |
| Investments And Advances | 129,062 | 185,836 | 292,792 | 112,407 | 112,592 |
| Other Non-Current Assets | 16,722 | 16,590 | 17,391 | 17,442 | 18,128 |
| TOTAL | $155,922 | $211,819 | $319,836 | $140,085 | $140,283 |
| Total Assets | $884,011 | $919,023 | $964,798 | $671,093 | $684,899 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,931 | 20,900 | 25,974 | 23,498 | 26,936 |
| TOTAL | $31,285 | $22,223 | $27,273 | $24,744 | $28,159 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,679 | 9,102 | 9,604 | 9,757 | 10,283 |
| TOTAL | $8,679 | $9,102 | $9,604 | $9,757 | $10,283 |
| Total Liabilities | $39,964 | $31,325 | $36,877 | $34,501 | $38,442 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,765 | 75,469 | 75,432 | 65,430 | 64,146 |
| Common Shares | 1,440,458 | 1,438,961 | 1,436,374 | 1,121,968 | 1,083,008 |
| Retained earnings | -770,995 | -713,071 | -665,140 | -620,397 | -571,935 |
| Other shareholders' equity | -2,212 | -1,769 | -77 | -2,953 | -3,299 |
| TOTAL | $844,047 | $887,698 | $927,921 | $636,592 | $646,457 |
| Total Liabilities And Equity | $884,011 | $919,023 | $964,798 | $671,093 | $684,899 |